-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 QuYmipNtunURCJYXfJYAavp2jq7RGjo4jklUuLRhqSiXa0hC5f+vcKe2Zr7eAEjd
 G0UQSbR4gMM2SublYe8VUg==

<SEC-DOCUMENT>0001075880-08-000054.txt : 20080804
<SEC-HEADER>0001075880-08-000054.hdr.sgml : 20080804
<ACCEPTANCE-DATETIME>20080804071416
ACCESSION NUMBER:		0001075880-08-000054
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20080804
FILED AS OF DATE:		20080804
DATE AS OF CHANGE:		20080804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVOGEN LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29962
		FILM NUMBER:		08986578

	BUSINESS ADDRESS:	
		STREET 1:		140 WICKS RD
		STREET 2:		NORTH RYDE
		CITY:			NEW SOUTH WALES 2113
		STATE:			C3
		ZIP:			2113
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		107 NORTH RYDE
		CITY:			SYDNEY
		STATE:			C3
		ZIP:			1670
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k20080804.htm
<DESCRIPTION>FORM 6K 2008 08 04
<TEXT>
<html>
  <head>
    <title>form6k20080804.htm</title>
<!-- Licensed to: Novogen Laboratories Pty Ltd-->
<!-- Document Created using EDGARizer 4.0.6.1 -->
<!-- Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved -->
</head>
    <body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; MARGIN-LEFT: 5%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 5%; FONT-FAMILY: Times New Roman">
    <div>
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
      <hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
    </div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 36pt; FONT-FAMILY: Times New Roman">UNITED
STATES</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 36pt; FONT-FAMILY: Times New Roman">SECURITIES
AND EXCHANGE COMMISSION</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman">Washington,
D.C. 20549</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">______________________________________________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman">Form
6-K</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman">REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman">SECURITIES
EXCHANGE ACT OF 1934</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">For the
month of August, 2008</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Commission
File Number <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">________________</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 36pt; FONT-FAMILY: Times New Roman">Novogen
Limited</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">(Translation
of registrant&#8217;s name into English)</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman">140 Wicks
Road, North Ryde, NSW, Australia</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">(Address
of principal executive office)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman">___________________________________</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Indicate
by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Form 20-F
<font style="DISPLAY: inline; FONT-WEIGHT: bold;" face="Wingdings">x</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>Form 40-F <font style="DISPLAY: inline; FONT-WEIGHT: bold;" face="Wingdings">o</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(l):<font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold;" face="Wingdings">o</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Note:
Regulation S-T Rule 101 (b)( I) only permits the submission in paper of a Form
6-K if submitted solely to provide an attached annual report to security
holders.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule lO1(b)(7): <font style="DISPLAY: inline; FONT-WEIGHT: bold;" face="Wingdings">o</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Note:
Regulation S-T Rule l01(b)(7) only permits the submission in paper of a Form 6-K
if submitted to furnish a report or other document that the registrant foreign
private issuer must furnish and make public under the laws of the jurisdiction
in which the registrant is incorporated, domiciled or legally organized (the
registrant&#8217;s &#8220;home country&#8221;), or under the rules of the home country exchange on
which the registrant&#8217;s securities are traded, as long as the report or other
document is not a press release, is not required to be and has not been
distributed to the registrant&#8217;s security holders, and, if discussing a material
event, has already been the subject of a Form 6-K submission or other Commission
filing on EDGAR.</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule l2g3-2(b) under the Securities Exchange Act of 1934. Yes <font style="DISPLAY: inline; FONT-WEIGHT: bold;" face="Wingdings">o</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">&#160;</font>No <font style="DISPLAY: inline; FONT-WEIGHT: bold;" face="Wingdings">x</font></font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">If &#8220;Yes&#8221;
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b):</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf </font>by the undersigned, thereunto duly
authorized.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Novogen
Limited</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">(Registrant)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">/s/&#160;&#160;Ron
Erratt</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Ronald
Lea Erratt</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Company
Secretary</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Date
1 August, 2008</font></div>
    <div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: right"><br></div>
    <div style="TEXT-ALIGN: right">
      <hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
      <hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
    </div>
    <div style="TEXT-ALIGN: right">&#160;</div>
    <div style="TEXT-ALIGN: right">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: right">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
      <div>&#160;</div>
      <div style="TEXT-ALIGN: right">&#160;</div>
      <div><img src="novogenletterhead.jpg" alt="Novogen logo"></div>
      <div>&#160;</div>
      <div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">1 August
2008</font></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Ms Emma
Badhni</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Company
Announcements Office</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">ASX
Limited</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">20 Bridge
Street</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Sydney
NSW 2000</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">By e-mail
emma.badhni@asx.com.au</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Dear Ms
Badhni</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Novogen
Limited (ASX Code: NRT)</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Notification
under section 708A(5)(e) of the <font style="DISPLAY: inline; FONT-STYLE: italic">Corporations Act</font> <font style="DISPLAY: inline; FONT-STYLE: italic">2001</font> (Cth)</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Novogen
Limited gives notice under section 708A(5)(e) of the <font style="DISPLAY: inline; FONT-STYLE: italic">Corporations Act 2001 </font>(Cth)
(<font style="DISPLAY: inline; FONT-WEIGHT: bold">Corporations Act</font>)
that:</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" id="list" width="100%">
              <tr valign="top">
                <td align="right" style="WIDTH: 36pt">
                  <div><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">1.&#160;&#160;</font></div>
                </td>
                <td>
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Novogen
      Limited has issued 4,531,633 ordinary shares under a placement without
      disclosure to investors under Part 6D.2 of the Corporations Act because
      disclosure is not required in these circumstances under Part
      6D.2.</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" id="list" width="100%">
              <tr valign="top">
                <td align="right" style="WIDTH: 36pt">
                  <div><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">2.&#160;&#160;</font></div>
                </td>
                <td>
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">As
      at today's date:</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" id="list" width="100%">
              <tr valign="top">
                <td align="right" style="WIDTH: 72pt">
                  <div><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;</font></div>
                </td>
                <td>
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Novogen
      Limited has complied with the provisions of Chapter 2M of the Corporations
      Act as they apply to Novogen
Limited;</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" id="list" width="100%">
              <tr valign="top">
                <td align="right" style="WIDTH: 72pt">
                  <div><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;</font></div>
                </td>
                <td>
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Novogen
      Limited has complied with sections 674 of the Corporations Act;
      and</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div>
          <table cellpadding="0" cellspacing="0" id="list" width="100%">
              <tr valign="top">
                <td align="right" style="WIDTH: 72pt">
                  <div><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;</font></div>
                </td>
                <td>
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">there
      is no "excluded information" within the meaning of sections 708A(7) and
      708A(8) of the Corporations Act which is required to be disclosed under
      section 708A(6)(e) of the Corporations
Act.</font></div>
                </td>
              </tr>
          </table>
        </div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Yours
sincerely</font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; TEXT-INDENT: 0pt; TEXT-ALIGN: left"><font><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">/s/ Ron
Erratt </font></font></div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 14pt; FONT-FAMILY: Times New Roman">Company
Secretary</font></div>
      </div>
    </div>
  </body>
</html>




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>novogenletterhead.jpg
<DESCRIPTION>NOVOGEN LOGO
<TEXT>
begin 644 novogenletterhead.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"`!E`/P#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`JM!<QRW=U`I^>%EW#ZJ"*LUYWJ?B>/PW\6UM[QQ'8ZE8PH
M[MP$D#N$8GTY(/U!/2FE<SJ34+-GHE%%%(T"BBB@`HHHH`****`"BBB@`HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHK.UG7-/T"S6[U*8PP,XC#!"WS$$@8
M`/H:&[;CC%R=HJ[-&BL_1]<T[7[,W>FW`GA5RC':5(8=B#SW'YUH4)WV"47%
MVDK,**R;KQ)I=EKEOHT]P5OK@`QQ^6QR#G'.,=C6M233'*$HV;6X457O;ZUT
MZU>YO;B*W@3[TDC!0/SKDI_BIX7AE*+/<2C^\D#8_7%)RBMV73H5:GP1;.UK
MQ'XX6I77-*NC]V6V:/\`[Y;/_L]>I:+XOT/Q`_E6%\C3XSY,@*/^`/7\,UQW
MQKTXW'AJROU4DVESM8^BN,']0M:4I+F31QX^E*-*49*S10^&'Q#\[R/#VLS?
MO>$L[AS]_P!(V/KZ'OTZXSZY7Q_].#7T)\,?&;>)=(:QOI-VIV:@.Q/,T?0/
M]>Q]\'O6E6%M4<N"Q/-^[GOT.\HHK+UOQ%I?AV"*;5+GR4E8JF$9B3C/0`U@
MVEJSTXQE-\L5=FI138W$D:N`0&`(##!_$=JY_6/''A[0YF@N[]6N%.&BA4R,
MOUQP/H:&TM6.%.<WRP5V=%17&6OQ2\+W,H1KF>#)QNEA('YC.*Z^WN(;J!)[
M>:.:%QE)(V#*P]B*2DGLRJE&I3^.+1)114%Y>VNGVS7-Y<16\"?>DE8*!^)J
MC-)MV1/17%W'Q2\+P2%%N9Y@#C='`V/UQ5O3_B)X8U&80IJ(AD8X`N$,8/XG
MC]:CVD>YN\)72NX/[CJ:**YS4_'7A[1]1FL+V]:.YAQO40NV,@$<@8Z$53:6
MYE"G.H[05WY'1T5R/_"S/"G_`$$7_P#`>3_XFMO1/$&F^(;>6?3)S-'$^QR4
M9<'`/<#L:2G%Z)ESP]6"YI1:7H:=%8>M^+M%\/7,=OJ=TT,LB>8H$3-D9QV!
M]*U[:YAO+6*YMY%D@E0/&Z]&4C(-.Z;L0Z<XQ4FM&2T45D:9XGTG5]2NM/LK
MDR7-J6$J&-EVX;:>2,'FBZ0E"4DVEL:]%%%,D*X'XN_\BA!_U^I_Z"]=]7`_
M%W_D4(/^OU/_`$%ZBK\#.O`_[S#U.1\-7T_@37=.DN7/]D:Q:0RL[=%W*#GZ
MJQ(/^R<^E>V=1D5PUQX:3Q/\+]*M5"B[CL89+9SV<1CC/H1P?S[5'\,_$KZA
MIKZ)?%EO]/&T!^&:,''/NI^4_A44_=?+T9T8M*O%UE\479_HS,\3?\EGT'_K
ME%_Z%)7ILLJ00O+*P2-%+,QZ`#DFO,O$W_)9]!_ZY1?^A25UOCV=[?P-JSH2
M"8?+X]&8*?T)IQ=N9DUX<_L8=TE^)YU;QW_Q4\5R/-+)!H]H<A1_`AZ`#IO;
M!))Z<^@%>G67A'P_I]L((-(M"H')DB$C-]6;)-8'PHMHX?!@F4#?<7$CN?H=
MH_1:[FBG%6YGNQ8VO)5'2AI&.ECS3QI\.[9+1]7\/Q&UN[;]ZT$1(#`<Y3^Z
MPZC'7ZU/H.I'XA^`-2TF\93J"1>4SG@,>L<GYKS[J?6O1*\D\`QC3OB=K>GP
M\0!9U`]`L@V_D"12:Y)IKJ.,OK.&G"IJXZI^75'CDL4D$KPS(4EC8HZ,,%6!
MP0?QK6\+:[)X;\266IH3LC?$RC^*,\,/RY'N!7<?%WP>]CJ!\1646;2Y(%T%
M'^KEZ!OHW\_K7E]>DFI(^,J0E0J6['U\CK)&LB,&1@"K`\$'O7F'B,?\)5\5
M=.T8?/::<`\P[9X=OSPBUN^`M>CE^&=K?W3Y%A`\<I]!%D#_`,="UE_"NSEO
M&U;Q+=C]_>SLBGVSN?'MD@?\!KSZJ]Y0/K<#*U*6(\K+U?\`DBS\3/%EQH]I
M#I.G.R7UXN6=/O1QYQ\O^TQR`?8]\&E\(_#73]-LX[G6+>.[U!QN9)/FCB]@
M.A/J3GGI6%?QC4?CM!!/S'"Z%1_N0^8/_'J];J8KGDY/H;UIO#T84J>G,KM^
MI@ZGX+\/:K;&&;2[>,X^62!!&Z^X(_D<BO.=+N[_`.&OC$:3>3F72;E@=Q^[
MM8X$@'8@C##T'T->R5YI\9+6-]&TVZ(_>)<-$#_LLI)_]!%%6-ES+="P-9SG
M["H[QE^'FCT>XN(K6VEN)W"11(7=CV4#)/Y5X_8VVH?%3Q'+=7LLEOHUHV%C
M0_=!Z*.V\CDMV_*NI\57\Q^$0N"Q,MQ:6X=NA.\H&_/)_.KGPRMH[?P)9.@&
MZ=Y)7/J=Y'\E`_"B7OR4>FXZ/^ST)55\5^5>7<U+/P?X=L81'#HUF0!C=)$)
M&/U+9)JI?_#_`,,Z@Z.VF1P.KALV_P"[#8.<$#@@]#Q^5=-2,RK]Y@/J:TY(
M[6.-8BJGS*3OZB@8&!TKRAK&TU'XX7UM>VT5Q`8P3'*H921"F.#7J]>-:QK+
MZ#\8-0OX[*2\9451#&<$YA3GH>GTJ*ME:_<ZLO4I2J*._*_T/2O^$/\`#?\`
MT`M/_P#`=?\`"M#3]+L-*B>/3[."U1VW,L*!03C&3BN!_P"%J7G_`$*=]_WV
MW_Q%>@:==&^TRTO&B:%IX4E,3=4+`'!^F<547!_"8UZ>(IK][L_._P"IY?\`
M$NS74?'>A6+N46YC2(N!DJ&D(S^M7/ASK%QI&IW7@[53LF@=C;9[]V4>Q'SC
MV)]JC\=_\E-\,?[T/_HZKOQ-\/RM##XFTW,=]8$&5DZE`<AOJI_0GTK&S4G)
M=#T5*,Z-.A/:2T\G?0]$KRKX=?\`)0O$G^]-_P"CC7=^%?$$/B708+^/"R_<
MGC'\$@ZCZ=Q[$5PGPZ_Y*%XD_P!Z;_T<:N33<6CEH0E"E6C+=)?F>JT445L>
M<%<#\7?^10@_Z_4_]!>N^KC?B9I5_J_AF&WT^UDN9A=HY1,9"A6&>?J*BI\+
M.K!-1Q$&^YM>$_\`D3]%_P"O&'_T`5PGCW3+GPQXCM?&&E)\ID`N4'`W].?9
MAP??!ZFO0/#EO-:>&-*MKB,QS16D22(W56"`$5:U&PM]4TZ>QNTWP3H4<>Q[
MCW'44G'FC8JG7]E7<MT[W\T>6ZEJ5OJ_Q3\,ZA:-N@N+>)USU'S29!]P<@_2
MO1_$>FMK'AS4-/3_`%D\#*G./FQE?U`KR30_">M:/\0+&.:QNI;:UNL"Z6)C
M&4P2&ST'7\#FO;ZFE=IW-\<XTY4_9N]EI]YYC\(];3[)=:#<-LN(I#-$C<$J
M<!E^H(S^/M7IU>>>+_A_<W6I_P!N^')A;ZB&\QXMVS>W]Y3V8]P>#[<YI1>-
MO&^GH;>_\*RW,ZC`E2%P"?4[05/X8HC)P7+(*U&.*E[6BU=[INS3/1-5U.VT
M?2[C4+MML,"%F]3Z`>Y.`/K7FOPHM+B_UG5_$-PN/,)C!QP7=M[X^GR_G44N
MA^,_'MU$VLK_`&9IR-N$97;CW"$Y+>[8QSCTKT[2=*M-%TR#3[*/9!"N!DY)
M/<D]R3S0KSDGT1,N3#494T[SEO;HB>ZM8+ZTEM;J))8)5*21N,A@>H-?.WCW
MP)<>$;[SH-TNDSMB&4\F,_W&]_0]_P`Z^CZJZCIUKJVG3V%[$LMM.A1T/IZ^
MQ'4'L173";BSQL1AXUHVZGSYHFOO;_#S4="B.9[N_3:@/)0J,X_%%'_`C7O7
MA[2ET3P_8Z:N"8(@KD?Q/U8_B237D7A'P+>:?\3'LKJ&5K/3W^T+.4(64#F/
MGIG)4D>Q%>X5$E^\<CJHSM@J=+KJWZW:7X(\B\=>;X:^)&G^(0C&"78[%>Y4
M;'7Z[,?G7K%M<0WEM%<V\BR0RJ'1UZ,IY!K/\0Z!9^)-)DL+P$`G='(OWHW'
M1A_GD$UYS:6GCKP$SV]G:C5=-W$JJ*9`,]PH.Y3ZCD?7K6.L)-]&>A[N*I1C
M=*<=->J/6Z\D^*>I'6-:T_PW8'S9D<%P#QYK\*OX`DG_`'JLW/B[QWK*&UTS
MPW-8LXP9GC;(^C.%4?CFMCP3X!.A7!U7595N=4?)&"66+=U.3RS')R?<_4DF
MZGNQV*HTXX1^UJM<RV2=]?,V]>T#[;X)N-$M^66V6.'/=D`*_JHKD_A-K\3Z
M=+H$[;+F!VDA5N"R$Y8?4-G/U]C7I=>>>+_AY+?:@=;\/S_9M1W>8\>[8';^
M\K#[K?H?;G+G%IJ43+#U83A*A5=D]4^S/0Z\T^,P!T/3<_\`/RW_`*`:JP>+
M_'VD@6VH>'9+QDX\P6[Y;_@294_@*S]=_P"$T\>106TGATVD,,A=2ZM%R1CD
MN1D8]!4SFI1:2U-\+A94:T:DY+E76Z/7K/\`X\;?_KFO\J\WM/\`DO%[_P!<
MO_:*5Z7;HT5M%&V-RH%./4"O+M9L/$^G_$F^UW2-&:[0JJQL^-C`Q*I_B!Z@
MU539>IA@K.5172O%K7Y'JM%><?\`"3_$3_H5;?\`(_\`Q==+X4U/Q#J*79U_
M2X[`H5\D)_&#G/\`$>G'YU2FF[&-3"RIQYFU\FCD/'?_`"4WPQ_O0_\`HZO3
MW19$9'4,C##*PR"/0UP'C#1-3O\`Q]X?OK2RDFM;=HC+*N,)B7)SSZ<UZ#2@
MO>D:8F2=*DD]E^IY%:._PU\?-:RLPT34>58]$7/!^J$X/^R<^E6/AUQ\0O$O
M^]-_Z.-=EXU\-)XG\/R6R!1>1?O+9SV<?PY]"./R/:N,^%FD:KI^O7\VH:?>
M6RO;X#SQ,H9MP/4]36?*XS2Z'8JT*N&G-OW[)/SMLSU:BBBN@\8****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**IPZI:7-Z;2!Y)7",QD2
M)VB&URC+YH&S>&!!3.X8/%7*`"BBL_1-;T[Q'H\&K:3<?:+&?=Y<NQDW;6*G
MA@".01R*`-"BBB@`HHHH`**IWFJ6EC<6MO,\AGNGVQ1Q1/(QY`+$*"50%E!<
MX5=PR1D5<H`**S]*UO3M;^V_V=<>=]ANY+*X^1EV3)C<O(&<9'(R/>M"@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`KD_'>F:UJMOH<&C27:(NL6[Z@;6[-N
MWV3#"3+!E)'(X!STQTKK**`/"_"WA7XH1WNGCQ%J6LBW#QAO(O5E*PEY1+'*
MWVA,$JX;S%61U&S:5*;:Z#P[H'C>+6-%GU>;4GLYGMWO(GU(YM3;6AC^8*YW
MB:=MY"DC"*7R6(7U2B@#PM[WQ7=?%:;3=/UZ2>[:XU1D:"_$UK!$+=5MEEA4
MD1F.4X;?&,L>KFJ\7A/XH.;5)+WQ!Y0LKEI8VU%8@EU]FVQ[9%NG>0&55/S;
M5!)(50S`>^44`?/DWA7XP_V-,C:EK+:DR(B_9[V/RWCVQ':TC7"E'4HP+)'E
MCNR[A\CL_$FF>-;KQIIL&D65];Z%:2VUO+=IJK$W-L0PG+!IP0P#@!MC2$KN
M$@(45ZA10!\\>'_!/Q*TB/2+6"WU6TTRVB4:E:1:LB_:?]++N(-LN(V,97D&
M/[KC/S?-IZCX5^*D^CVZM?:E)?PZ%'&K6VJ^4/M?VO.&PZAG%N2"QR"1]YC@
MU[I10!XW\19O%=S\26TWPO/J37B:%%=VT%O>"*))5N\-(Z,ZHX*!EP0V=PXP
M,C#T'PC\1?#6GZ=9VVE7TMK+IYANX%UC:EM,;QG,B(MPF6\I5&$=`=YR>6!^
M@**`/"WT#XLR:9:3F;4AJ=IHZ)&%U)`K7:WN1O4/LD/V;J7!#=\M5B]T/XEV
M%^)]/MM2U""&]U*&*VEULHKVCH!;,Y\T,Q5GD8$GS/E`W+A"/;**`/'_``CH
M_P`0K?Q-#+XF35;C1(I9ELX(=15'@)EC9))\3EI(]N\;6DF(P1@C!.7;Z!\5
M;34M.N;F[UF\,6IQS:A#!=0K!<1)*[%HV:X!PRL!Y8CB0C;D97)]THH`^?-+
M\"_$BV\6^$=8G74C+&D4>KW$FK!V*"[=F0YD)9/*\L[5R#Z9S6W=Z5\15\+G
M35TW5;G6YI;A[S5EUG;&6!E\DV\:W$>U3O7(*JH"C,;D`#VBB@#P?3?#'Q'L
M/!L^;*^.NW&MSZA-;PWL4,-P'CC4F5XIHW7YB[*$;&5PRX*D>\444`%%%%`!
M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
5%%`!1110`4444`%%%%`!1110!__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
